Results 131 to 140 of about 529,483 (274)

Strategies for Paired Electrolysis with Enhanced Efficiency

open access: yesAdvanced Energy and Sustainability Research, EarlyView.
This review summarizes the fundamentals, challenges, and strategies for paired electrolysis, with examples in the chlor‐alkali, hydrogen production, CO2 reduction, and ammonia synthesis industries. Future directions include the development of advanced membranes, computational studies, process integration, scale‐up, and techno‐economic analysis.
Yuanyuan Yao   +6 more
wiley   +1 more source

Conversion Therapy for cT4b and M1 Esophageal Squamous Cell Carcinoma: A Comprehensive Systematic Review

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley   +1 more source

Universal Catalyst Design Framework for Electrochemical Hydrogen Peroxide Synthesis Facilitated by Local Atomic Environment Descriptors

open access: yesAngewandte Chemie, EarlyView.
A universal catalyst design framework integrating weighted atom‐centered symmetry function (wACSF) descriptors with machine learning accurately predicts adsorption energies for 2e− water oxidation reaction. Microkinetic modeling and experimental validation confirm the framework's universality, establishing a powerful paradigm for rational ...
Zhijian Liu   +17 more
wiley   +2 more sources

Current Status of Multidisciplinary Treatment Strategies for Hepatocellular Carcinoma in the Era of Advanced Systemic Therapies

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT The therapeutic landscape of hepatocellular carcinoma (HCC) has been transformed by recent advancements in systemic therapies, particularly with the introduction of immune checkpoint inhibitors, expanding treatment options beyond conventional locoregional approaches.
Keiichi Akahoshi   +4 more
wiley   +1 more source

Harnessing Controlled Dealloying–Support Coupling for Ultrastable PtNi Catalysts in PEMFC Applications

open access: yesAngewandte Chemie, EarlyView.
A controllable alloying–dealloying strategy constructs PtNi core–shell nanoparticles confined within an N‐doped carbon framework. Selective ammonia‐assisted dealloying forms a Pt‐rich shell while immobilizing Ni as Ni–N/C moieties, synergistically stabilizing the catalyst.
Fei Guo   +14 more
wiley   +2 more sources

Advancements in Graphdiyne‐Based Multiscale Catalysts for Green Hydrogen Energy Conversion

open access: yesAdvanced Intelligent Discovery, EarlyView.
This review systematically explores the fundamental characteristics of graphdiyne (GDY), cutting‐edge field of GDY‐based multiscale catalysts within sustainable energy conversion systems.Special emphasis is placed on the structure‒property relationships in different reactions.
Qian Xiao, Lu Qi, Siao Chen, Yurui Xue
wiley   +1 more source

Associations between Specialist Tactical Response Police Unit Selection Success and Urban Rush, along with 2.4 km and 10 km Loaded Carriage Events [PDF]

open access: yes, 2012
Rhiannon Thomas   +23 more
core   +1 more source

FastCat: Autonomous Discovery of Multielement Layered Double Hydroxide Alloy Catalysts for Alkaline Oxygen Evolution Reaction

open access: yesAdvanced Intelligent Discovery, EarlyView.
A machine learning‐guided self‐driving laboratory screened over 500 nickel‐based layered double‐hydroxide catalysts for alkaline oxygen evolution. Out of the eight metals, the robot uncovered a quaternary Ni–Fe–Cr–Co catalysts requiring only 231 mV overpotential to reach 20 mA cm−2.
Nis Fisker‐Bødker   +3 more
wiley   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy